Mutations in the FTO gene raise blood levels of leptin, a known mediator or growth factor between obesity and colon cancer, which activates a variety of pathways associated with colon cancer (Drew, 2012; Mehrdad et al., 2020a). Here, LEP is linked to obesity disorder.